Form 4: Pfizer Executive Rady A. Johnson Reports Stock Appreciation Rights Acquisition

Executive Vice President Rady A. Johnson reports the acquisition of stock appreciation rights related to Pfizer common stock.

Summary

• On February 27, 2024, Rady A. Johnson, an Executive Vice President at Pfizer Inc., reported the acquisition of stock appreciation rights (SARs).
• Johnson acquired 38,678 SARs that will be settled in Pfizer common stock on February 27, 2029, subject to certain vesting requirements.
• Additionally, Johnson acquired 34,176 SARs that will be settled in Pfizer common stock on February 27, 2031, also subject to vesting requirements.
• The exercise price for both sets of SARs is $26.89, and the price of the derivative security is $0.0000.
• Following the reported transaction, Johnson directly owns 38,678 and 34,176 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard executive compensation transaction. It doesn't inherently indicate positive or negative performance, but rather aligns executive interests with the company's stock performance.

Positives

• The acquisition of stock appreciation rights by a high-ranking executive could be interpreted as a sign of confidence in the company's future performance.

Future Outlook

The stock appreciation rights are subject to vesting requirements and will be settled in shares of Pfizer common stock on the fifth and seventh anniversary of the grant date.

Industry Context

Stock appreciation rights are a common form of executive compensation in the pharmaceutical industry, aligning executive incentives with shareholder value by rewarding increases in the company's stock price.

Comparison to Industry Standards

• Companies like Johnson & Johnson, Merck, and AbbVie also utilize stock appreciation rights as part of their executive compensation packages.
• The vesting schedules and settlement terms are generally comparable to industry norms, with vesting periods typically ranging from three to five years.

Stakeholder Impact

• The acquisition of stock appreciation rights aligns the executive's interests with those of the shareholders, as the value of the rights increases with the company's stock price.

Key Dates